Motley Fool Australia

Medlab Clinical Ltd (ASX: MDC) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $81.11 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 279.68 million
Earnings per share -0.046
Dividend per share N/A
Year To Date Return 33.33%
Earnings Yield N/A
Franking N/A

Medlab Clinical Ltd (ASX: MDC) Latest News

Here’s why the Medlab (ASX:MDC) share price is rising today

More »

asx shares higher

Why Clean TeQ, Medlab, Newcrest, & Ramelius are storming higher today

More »

marijuana leaf with upward facing arrow

Why this ASX cannabis share is shooting 15% higher today

More »

increasing cannabis asx share price represented by growing coin piles with cannabis plants on top

Why THC Global and these ASX cannabis shares are rocketing higher today

More »

Health technology shares

Why this ASX biotech is printing 52-week highs

More »

ASX Pot Stocks

This small-cap ASX biotech’s share price is soaring today

More »

share price high

Why Medlab, Metcash, SKY and Space Global, and WiseTech shares charged higher today

More »

These small cap ASX shares are on the rise today

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Medlab Clinical Ltd (ASX: MDC)

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
05 Mar 2021 $0.29 $-0.02 -6.45% 642,466 $0.31 $0.31 $0.29
04 Mar 2021 $0.31 $-0.01 -3.13% 312,200 $0.32 $0.32 $0.31
03 Mar 2021 $0.32 $-0.01 -3.08% 307,547 $0.33 $0.33 $0.32
02 Mar 2021 $0.33 $-0.01 -3.03% 138,274 $0.33 $0.34 $0.33
01 Mar 2021 $0.33 $0.01 3.08% 219,600 $0.32 $0.34 $0.32
26 Feb 2021 $0.33 $0.00 0.00% 328,907 $0.33 $0.33 $0.32
25 Feb 2021 $0.33 $-0.01 -2.99% 206,902 $0.34 $0.34 $0.33
24 Feb 2021 $0.34 $-0.01 -2.90% 613,708 $0.36 $0.36 $0.33
23 Feb 2021 $0.35 $-0.02 -5.56% 135,646 $0.36 $0.36 $0.35
22 Feb 2021 $0.36 $0.03 9.09% 645,460 $0.36 $0.36 $0.34
19 Feb 2021 $0.33 $-0.02 -5.71% 656,439 $0.35 $0.36 $0.32
18 Feb 2021 $0.35 $0.03 9.23% 1,179,365 $0.35 $0.36 $0.33
17 Feb 2021 $0.33 $-0.02 -5.88% 149,805 $0.34 $0.34 $0.32
16 Feb 2021 $0.34 $0.00 0.00% 604,094 $0.35 $0.35 $0.31
15 Feb 2021 $0.35 $0.02 6.06% 477,067 $0.34 $0.35 $0.34
12 Feb 2021 $0.33 $-0.02 -5.71% 558,324 $0.35 $0.35 $0.32
11 Feb 2021 $0.35 $0.05 16.67% 1,258,672 $0.34 $0.35 $0.34
10 Feb 2021 $0.30 $-0.02 -6.25% 559,501 $0.32 $0.32 $0.30
09 Feb 2021 $0.32 $0.00 0.00% 214,718 $0.33 $0.33 $0.31
08 Feb 2021 $0.32 $-0.01 -3.08% 660,550 $0.33 $0.34 $0.32
05 Feb 2021 $0.33 $0.01 3.17% 564,961 $0.33 $0.33 $0.31
04 Feb 2021 $0.32 $0.01 3.23% 415,701 $0.32 $0.32 $0.31
03 Feb 2021 $0.31 $0.01 3.33% 408,209 $0.31 $0.33 $0.31
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
14 Dec 2020 Michael Hall Sell 100 $27,500
12 Nov 2020 Sean Hall Issued 4 $740,000
12 Nov 2020 Laurence (Laurie) McAllister Issued 4 $740,000
12 Nov 2020 Drew Townsend Issued 2 $370,000
12 Nov 2020 Michael Hall Issued 2 $370,000
14 Apr 2020 Michael Hall Sell 68 $18,645


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Drew Anthony Townsend Non-Executive Director Jun 2014
Mr Michael Jack Hall Non-Executive Chairman,Non-Executive Director Apr 2015
Mr Sean Michael Hall Chief Executive Officer,Managing Director Apr 2014
Mr Laurence (Laurie) McAllister Non-Executive Director Aug 2020
Mr Alan Dworkin Chief Financial Officer,Company Secretary Feb 2015
Alan Dworkin Chief Financial Officer,Company Secretary
Ian Curtinsmith Chief Information Officer
Luis Vitetta Director of Medical Research
David Rutolo Director of Science
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Sean Michael Hall 57,925,555 20.71%
Farjoy Pty Ltd 30,849,322 11.03%
Fit Investments Pty Ltd <Hallab Investment A/C> 12,334,445 4.41%
Realm Group Pty Ltd 10,500,000 3.75%
UBS Nominees Pty Ltd 9,255,665 3.31%
J P Morgan Nominees Australia Pty Limited 7,203,560 2.58%
HSBC Custody Nominees (Australia) Limited 6,455,054 2.31%
Richard Albarran <Albarran Family No 2 A/C> 5,555,553 1.99%
United Trolley Collections P/L 4,945,500 1.77%
Citicorp Nominees Pty Limited 4,061,331 1.45%
Rolay Pty Ltd 3,750,000 1.34%
Mr Michael Jack Hall + Mrs Elizabeth Ann Jones <Hall Jones Super Fund A/C> 3,572,938 1.28%
Villamagna Inc 3,000,000 1.07%
Acron Holdings Pty Limited <Acron Super Fund A/C> 2,840,055 1.02%
Netwealth Investments Limited 2,303,463 0.82%
D J Fairfull Pty Ltd <Fairfull Super Fund A/C> 1,897,534 0.68%
Equitas Nominees Pty Ltd 1,850,000 0.66%
Rolay Pty Limited 1,805,553 0.65%
Legend Developments Pty Ltd <A&D Dworkin Family A/C> 1,761,111 0.63%
BNP Paribas Nominees Pty Ltd 1,630,323 0.58%
Show more